GlassScriptPhysician profile
Seth P Lerner
NPI 1669552063
$97,872.73
in general payments reported to CMS, 2019-2025
21 companies · $9,509 in 2025
The $9,509 reported for 2025 was more than what 94% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $23K · 2021: $13K · 2022: $8,757 · 2023: $20K · 2024: $9,778 · 2025: $9,509.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $34K · Travel and Lodging: $2,257 · Food and Beverage: $1,414 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,100 · Honoraria: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $34,148.87 |
| Travel and Lodging | $2,257.13 |
| Food and Beverage | $1,414.16 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,100.00 |
| Honoraria | $200.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals As | $18,490.66 | 2022-2025 | Adstiladrin |
| Urogen Pharma, INC. | $16,230.00 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $16,008.51 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $12,859.01 | 2019-2025 | Adstiladrin |
| E.R. Squibb & Sons, L.L.C. | $9,378.40 | 2021-2024 | |
| Gilead Sciences, INC. | $4,866.41 | 2024 | Trodelvy |
| Ferring International Center Sa | $4,822.37 | 2023 | |
| Genentech, INC. | $4,302.44 | 2019-2022 | |
| Astrazeneca Uk Limited | $3,490.50 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $2,148.00 | 2021 | |
| Pfizer INC. | $2,000.00 | 2020 | |
| Verity Pharmaceuticals INC. | $1,600.00 | 2020 | |
| Genentech USA, INC. | $900.27 | 2019-2024 | |
| Immunitybio, INC. | $200.00 | 2024 | |
| Qed Therapeutics, INC. | $134.91 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $130.92 | 2021-2024 | Lux-Dx Insertable Cardiac Monitor |
| Emd Serono, INC. | $86.57 | 2022 | |
| Allergan, INC. | $76.24 | 2019 | |
| Intuitive Surgical, INC. | $60.28 | 2021-2022 | |
| Abc Home Medical Supply, INC. | $51.10 | 2025 | |
| Janssen Global Services, LLC | $36.14 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Seth Lerner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.